Benzinga | Oct 7, 2021 08:57AM EDT

Morgan Stanley Maintains Overweight on Aptiv, Raises Price Target to $217

Morgan Stanley analyst Adam Jonas maintains Aptiv (NYSE:APTV) with a Overweight and raises the price target from $210 to $217.